526 related articles for article (PubMed ID: 21985837)
21. ACE inhibitor-induced angioedema.
Baram M; Kommuri A; Sellers SA; Cohn JR
J Allergy Clin Immunol Pract; 2013; 1(5):442-5. PubMed ID: 24565614
[TBL] [Abstract][Full Text] [Related]
22. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
Culley CM; DiBridge JN; Wilson GL
Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
[TBL] [Abstract][Full Text] [Related]
23. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.
Jeon J; Lee YJ; Lee SY
J Clin Pharm Ther; 2019 Oct; 44(5):685-692. PubMed ID: 31290163
[TBL] [Abstract][Full Text] [Related]
24. Treatment with icatibant in the management of drug induced angioedema.
Bertazzoni G; Bresciani E; Cipollone L; Fante E; Galandrini R
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):149-53. PubMed ID: 25635988
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review.
Lawlor CM; Ananth A; Barton BM; Flowers TC; McCoul ED
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):232-239. PubMed ID: 29112487
[TBL] [Abstract][Full Text] [Related]
26. Two cases of severe angio-oedema and rationale for their response to icatibant.
Akinduro OO; Patel V; Thomas T; Ahmad FU
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26678695
[No Abstract] [Full Text] [Related]
27. The Angiotensin-Converting-Enzyme-Induced Angioedema.
Bas M
Immunol Allergy Clin North Am; 2017 Feb; 37(1):183-200. PubMed ID: 27886906
[TBL] [Abstract][Full Text] [Related]
28. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
Nielsen EW; Gramstad S
Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
[TBL] [Abstract][Full Text] [Related]
29. Commentary regarding: A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
Yancey KB
Dermatol Ther; 2015; 28(5):331. PubMed ID: 25818322
[No Abstract] [Full Text] [Related]
30. Angiotensin converting enzyme inhibitor-induced angioedema: a report of two cases.
Assadi FK; Wang HE; Lawless S; McKay CP; Hopp L; Fattori D
Pediatr Nephrol; 1999 Nov; 13(9):917-9. PubMed ID: 10603148
[TBL] [Abstract][Full Text] [Related]
31. [ACE-inhibitor induced angioedema].
Bas M; Hoffmann TK; Kojda G; Bier H
Laryngorhinootologie; 2007 Nov; 86(11):804-8, quiz 809-13. PubMed ID: 17966084
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it.
Beltrami L; Zingale LC; Carugo S; Cicardi M
Expert Opin Drug Saf; 2006 Sep; 5(5):643-9. PubMed ID: 16907654
[TBL] [Abstract][Full Text] [Related]
33. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
Cheong E; Dodd L; Smith W; Kleinig T
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
[TBL] [Abstract][Full Text] [Related]
34. Icatibant in ACE-inhibitor-induced angioedema.
Armengol G; Faisant C; Benhamou Y
N Engl J Med; 2015 May; 372(19):1867. PubMed ID: 25946294
[No Abstract] [Full Text] [Related]
35. Icatibant in ACE-inhibitor-induced angioedema.
Soo Hoo GW; Klaustermeyer WB
N Engl J Med; 2015 May; 372(19):1866. PubMed ID: 25946293
[No Abstract] [Full Text] [Related]
36. Icatibant in ACE-inhibitor-induced angioedema.
Tomkiewicz W
N Engl J Med; 2015 May; 372(19):1866. PubMed ID: 25946292
[No Abstract] [Full Text] [Related]
37. Icatibant in ACE-inhibitor-induced angioedema.
Baş M; Hoffmann TK; Kojda G
N Engl J Med; 2015 May; 372(19):1867-8. PubMed ID: 25946291
[No Abstract] [Full Text] [Related]
38. Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist.
Pucar PA; O'Sullivan M; Goudie A; Marr T; Brusch A
Med J Aust; 2015 Jun; 202(11):596-7. PubMed ID: 26068694
[No Abstract] [Full Text] [Related]
39. Angiotensin-converting enzyme inhibitor-induced angioedema and icatibant: a new hope.
Jacob J; Bardes I; Palom X; Carrizosa M; Fuentes E
Intern Med J; 2015 Oct; 45(10):1093-4. PubMed ID: 26429224
[No Abstract] [Full Text] [Related]
40. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
